Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,581 | 860 | 99.6% |
| Education | $41.10 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,424 | 108 | $0 (2024) |
| Novo Nordisk Inc | $1,376 | 152 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $854.67 | 48 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $847.13 | 66 | $0 (2024) |
| Lilly USA, LLC | $769.28 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $547.47 | 47 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $542.63 | 36 | $0 (2023) |
| PFIZER INC. | $469.83 | 42 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $469.60 | 37 | $0 (2023) |
| Amgen Inc. | $394.55 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $679.84 | 43 | ABBVIE INC. ($204.41) |
| 2023 | $1,771 | 123 | ABBVIE INC. ($329.98) |
| 2022 | $1,969 | 128 | ABBVIE INC. ($320.37) |
| 2021 | $2,142 | 146 | AbbVie Inc. ($426.93) |
| 2020 | $1,170 | 105 | Novo Nordisk Inc ($259.44) |
| 2019 | $1,057 | 93 | Novo Nordisk Inc ($288.45) |
| 2018 | $1,271 | 104 | Novo Nordisk Inc ($244.83) |
| 2017 | $1,563 | 123 | AstraZeneca Pharmaceuticals LP ($233.18) |
All Payment Transactions
865 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: PAIN | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: PAIN | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Endocrinology | ||||||
| 07/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.03 | General |
| 06/18/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Gastroenterology | ||||||
| 03/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 253 | 338 | $69,918 | $24,843 |
| 2022 | 7 | 279 | 369 | $72,511 | $27,125 |
| 2021 | 6 | 306 | 443 | $88,470 | $34,743 |
| 2020 | 10 | 500 | 612 | $135,436 | $46,273 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $28,044 | $10,059 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 129 | $26,507 | $9,267 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 109 | $15,151 | $5,477 | 36.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 18 | $216.00 | $39.60 | 18.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $31,132 | $11,904 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 125 | $25,750 | $8,662 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 88 | $12,232 | $4,633 | 37.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,277 | $1,451 | 63.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $433.00 | $302.49 | 69.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 13 | $468.00 | $124.60 | 26.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 22 | $219.00 | $48.77 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 219 | $45,114 | $16,655 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 109 | 109 | $32,155 | $13,742 | 42.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 73 | $10,147 | $3,904 | 38.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $525.00 | $237.49 | 45.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $385.00 | $167.92 | 43.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 13 | 16 | $144.00 | $36.00 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 134 | 134 | $39,530 | $14,908 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 99 | 179 | $25,061 | $7,669 | 30.6% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 28 | 28 | $18,665 | $6,424 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 108 | $22,736 | $5,868 | 25.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 30 | 30 | $8,930 | $3,574 | 40.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 20 | 20 | $8,740 | $3,299 | 37.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 13 | 13 | $5,512 | $2,088 | 37.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 19 | $2,299 | $1,159 | 50.4% |
About Dr. Andreana Hodgini, DO
Dr. Andreana Hodgini, DO is a Family Medicine healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821033317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andreana Hodgini, DO has received a total of $11,622 in payments from pharmaceutical and medical device companies, with $679.84 received in 2024. These payments were reported across 865 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,581).
As a Medicare-enrolled provider, Hodgini has provided services to 1,338 Medicare beneficiaries, totaling 1,762 services with total Medicare billing of $132,983. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fort Wayne, IN
- Active Since 06/18/2006
- Last Updated 03/02/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821033317
Products in Payments
- Ozempic (Drug) $660.43
- QELBREE (Drug) $646.10
- VRAYLAR (Drug) $515.80
- UBRELVY (Drug) $483.77
- FARXIGA (Drug) $433.28
- Kerendia (Drug) $432.71
- XIFAXAN (Drug) $392.17
- XARELTO (Drug) $348.47
- TRELEGY ELLIPTA (Drug) $328.74
- EMGALITY (Drug) $283.66
- QULIPTA (Drug) $212.73
- VYVANSE (Drug) $212.30
- NURTEC ODT (Drug) $210.01
- Victoza (Drug) $207.46
- Aimovig (Biological) $191.67
- Vascepa (Drug) $179.39
- BEVESPI AEROSPHERE (Drug) $178.16
- MOUNJARO (Drug) $173.56
- SYMBICORT (Drug) $169.32
- TROKENDI XR (Drug) $166.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fort Wayne
Brianna Serbus, Md, MD
Family Medicine — Payments: $188,058
Brian Adams, Md, MD
Family Medicine — Payments: $164,966
Thomas Kintanar, Md, MD
Family Medicine — Payments: $153,802
Charles Coats, Md, MD
Family Medicine — Payments: $65,891
Peter Jakacki, Md, MD
Family Medicine — Payments: $28,192
Dr. Nehal Singh, M.d, M.D
Family Medicine — Payments: $22,821